%0 Journal Article %A Bhavneet Walia %A Brittany L. Kmush %A Sandra D. Lane %A Timothy Endy %A Antonio Montresor %A David A. Larsen %T Routine deworming during antenatal care decreases risk of neonatal mortality and low birthweight: a retrospective cohort of survey data %D 2020 %R 10.1101/2020.04.07.20057000 %J medRxiv %P 2020.04.07.20057000 %X Background Soil transmitted helminths (STH) are a common infection among pregnant women in areas with poor access to sanitation. Deworming medications are cheap and safe; however, the health benefit of deworming during pregnancy is not clear.Methods / Principal Findings We created a retrospective cohort of more than 800,000 births from 95 Demographic and Health Survey datasets to estimate the impact of deworming medicine during routine antenatal care (ANC) on neonatal mortality and low birthweight. We first matched births on the probability of receiving deworming during ANC. We then modeled the birth outcomes with the matched group as a random intercept to estimate the effect of deworming during antenatal care after accounting for various risk factors. We also tested for effect modification of soil transmitted helminth prevalence on the impact of deworming during ANC. Receipt of deworming medication during ANC was associated with a 15% reduction in the risk of neonatal mortality (95% confidence interval = 11-18%, n = 797,772 births), with no difference between high and low transmission countries. In low transmission countries, we found an 11% reduction in the odds of low birth weight (95% confidence interval = 8-13%) for women receiving deworming medicine and in high transmission we found a 3% reduction in the odds of low birthweight (95% confidence interval = 1-5%).Conclusions / Significance These results suggest a substantial health benefit for deworming during ANC that may be even greater in countries with low STH transmission.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no funding for this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data utilized in this manuscript are publicly available from the Demographic and Health Surveys program https://dhsprogram.com ANCantenatal careCIconfidence intervalDHSdemographic health surveyIRRincident rate ratioLRlikelihood ratioORodds ratio %U https://www.medrxiv.org/content/medrxiv/early/2020/04/10/2020.04.07.20057000.full.pdf